Evidence map›Paper›PMID 20302191›Full record

ReviewJournal of medicine and life

Spinal muscular atrophy disease: a literature review for therapeutic strategies.

M Stavarachi, P Apostol, M Toma, D Cimponeriu, L Gavrila

Abstract readReview
In one paragraph

Review in Journal of medicine and life. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Drug treatment for spinal muscular atrophy types II and III.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Drug treatment for spinal muscular atrophy type I.The Cochrane database of systematic reviews · 2019
    Pooled it
  3. Sorting differentiated mammalian cells using deterministic lateral displacement microfluidic devices.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2024
    Article
  4. Review
  5. Review
  6. Perceptions of equine-assisted activities and therapies by parents and children with spinal muscular atrophy.Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association · 2014
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M StavarachiHuman Genetics and Molecular Diagnosis Department, Institute of Genetics, 1-3 Portocalelor Street, District 6, postal code 060101, Bucharest, Romania. monica.stavarachi@gmail.com
P Apostol
M Toma
D Cimponeriu
L Gavrila

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, there is no cure for the treatment of spinal muscular atrophy (SMA). Based on the available clinical and molecular findings, different therapeutic strategies were tested in vitro and in vivo and clinical trials are ongoing. The main therapeutic direction is focused on the enhancement of SMN expression by increasing the full-length (fl) SMN2 transcript levels, preventing the SMN exon 7 from skipping or from protein stabilizing. In addition, the action of neurotrophic, neuroprotective or anabolic agents is tested and stem cell and gene therapy approaches are in a promising development.

Indexed as

Anabolic AgentsExonsGenetic TherapyHumansMuscular Atrophy, SpinalNeuroprotective AgentsPromoter Regions, GeneticStem Cell TransplantationSurvival of Motor Neuron 2 ProteinAnabolic AgentsNeuroprotective AgentsSMN2 protein, humanSurvival of Motor Neuron 2 Protein

Identifiers

PMID20302191
PMCPMC3019038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.